Transcend Capital Advisors LLC Raises Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

Transcend Capital Advisors LLC boosted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMOGet Rating) by 5.8% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 6,960 shares of the medical research company’s stock after acquiring an additional 382 shares during the quarter. Transcend Capital Advisors LLC’s holdings in Thermo Fisher Scientific were worth $3,781,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of TMO. Mirae Asset Global Investments Co. Ltd. grew its holdings in Thermo Fisher Scientific by 16.2% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 51,855 shares of the medical research company’s stock worth $30,628,000 after purchasing an additional 7,238 shares during the last quarter. Kovitz Investment Group Partners LLC lifted its stake in shares of Thermo Fisher Scientific by 1,359.7% during the first quarter. Kovitz Investment Group Partners LLC now owns 10,612 shares of the medical research company’s stock worth $6,268,000 after buying an additional 9,885 shares during the period. Marietta Wealth Management LLC lifted its stake in shares of Thermo Fisher Scientific by 4.3% during the first quarter. Marietta Wealth Management LLC now owns 12,912 shares of the medical research company’s stock worth $7,626,000 after buying an additional 529 shares during the period. California State Teachers Retirement System lifted its stake in shares of Thermo Fisher Scientific by 0.6% during the fourth quarter. California State Teachers Retirement System now owns 708,079 shares of the medical research company’s stock worth $472,459,000 after buying an additional 4,340 shares during the period. Finally, Kingfisher Capital LLC lifted its stake in shares of Thermo Fisher Scientific by 1.6% during the first quarter. Kingfisher Capital LLC now owns 8,200 shares of the medical research company’s stock worth $4,843,000 after buying an additional 133 shares during the period. 86.50% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Thermo Fisher Scientific

In other news, CFO Stephen Williamson sold 15,000 shares of the business’s stock in a transaction dated Friday, August 12th. The shares were sold at an average price of $601.32, for a total transaction of $9,019,800.00. Following the completion of the sale, the chief financial officer now owns 43,944 shares of the company’s stock, valued at $26,424,406.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CFO Stephen Williamson sold 15,000 shares of the business’s stock in a transaction dated Friday, August 12th. The shares were sold at an average price of $601.32, for a total transaction of $9,019,800.00. Following the completion of the sale, the chief financial officer now owns 43,944 shares of the company’s stock, valued at $26,424,406.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Michael A. Boxer sold 7,283 shares of the company’s stock in a transaction dated Monday, August 8th. The shares were sold at an average price of $590.80, for a total transaction of $4,302,796.40. Following the sale, the senior vice president now directly owns 12,398 shares of the company’s stock, valued at approximately $7,324,738.40. The disclosure for this sale can be found here. Insiders sold 55,397 shares of company stock valued at $33,012,754 over the last 90 days. Corporate insiders own 0.43% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. SVB Leerink lifted their price objective on shares of Thermo Fisher Scientific from $630.00 to $650.00 and gave the stock an “outperform” rating in a research note on Friday, July 29th. Morgan Stanley boosted their target price on shares of Thermo Fisher Scientific from $670.00 to $678.00 and gave the company an “overweight” rating in a research report on Friday, July 29th. Credit Suisse Group started coverage on shares of Thermo Fisher Scientific in a research report on Wednesday, August 24th. They set a “neutral” rating and a $675.00 target price for the company. Finally, Barclays decreased their target price on shares of Thermo Fisher Scientific from $685.00 to $595.00 and set an “overweight” rating for the company in a research report on Monday, September 12th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $655.64.

Thermo Fisher Scientific Trading Down 0.8 %

Shares of Thermo Fisher Scientific stock opened at $537.00 on Monday. The firm has a 50-day simple moving average of $568.00 and a two-hundred day simple moving average of $558.78. The company has a market cap of $210.39 billion, a P/E ratio of 28.81, a price-to-earnings-growth ratio of 1.69 and a beta of 0.85. Thermo Fisher Scientific Inc. has a fifty-two week low of $497.83 and a fifty-two week high of $672.34. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.13 and a current ratio of 1.65.

Thermo Fisher Scientific (NYSE:TMOGet Rating) last issued its quarterly earnings data on Thursday, July 28th. The medical research company reported $5.51 earnings per share for the quarter, topping analysts’ consensus estimates of $4.92 by $0.59. The business had revenue of $10.97 billion during the quarter, compared to the consensus estimate of $9.95 billion. Thermo Fisher Scientific had a net margin of 17.37% and a return on equity of 24.36%. The company’s revenue was up 18.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $5.60 earnings per share. As a group, equities analysts predict that Thermo Fisher Scientific Inc. will post 22.92 earnings per share for the current fiscal year.

Thermo Fisher Scientific Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 14th. Stockholders of record on Thursday, September 15th will be paid a dividend of $0.30 per share. The ex-dividend date is Wednesday, September 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 0.22%. Thermo Fisher Scientific’s dividend payout ratio is currently 6.39%.

About Thermo Fisher Scientific

(Get Rating)

Thermo Fisher Scientific Inc offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Read More

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMOGet Rating).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.